Moderna vs Poplar Therapeutics
Moderna vs Poplar Therapeutics, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Moderna is on 77/100 and Poplar Therapeutics on 51/100.
Where each one leads
Moderna
- our overall score: 77/100 against 51/100
- agent readiness: 49/100 against 40/100
- domain rating: 79/100 against 4/100
- headcount: 6,297 against 15
- funding raised: $4.5B against $50.0M
- LinkedIn following: 780,086 against 1,205
Poplar Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Moderna | Poplar Therapeutics |
|---|---|---|
| What it is | Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics. | Developing a new class of anti-IgE therapy for multiple atopic conditions. |
| Category | Biotechnology, mRNA Technology, Vaccines, Pharmaceuticals | Biotechnology, Pharmaceuticals, HealthTech, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2010 | 2021 |
| Headquarters | Cambridge, United States | Boston, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Moderna | Poplar Therapeutics |
|---|---|---|
| Employees | 6,297 | 15 |
| Open roles | 100 | Not published |
| Total funding | $4.5B | $50.0M |
| Latest round | Funding Round | Series A |
| LinkedIn followers | 780,086 | 1,205 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Moderna | Poplar Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 77/100 | 51/100 |
| Traction | 60/100 | 51/100 |
| Team | 70/100 | 30/100 |
| Community | 13/100 | Not published |
| Search visibility | 46/100 | 25/100 |
| Quality | 90/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (49/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 79/100 | 4/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Moderna | Poplar Therapeutics |
|---|---|---|
| Hosting | AWS | Not detected |
| CDN | CloudFront | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Next.js | Jquery |
| Analytics | Not detected | Google Analytics 4 |
What users say
| Measure | Moderna | Poplar Therapeutics |
|---|---|---|
| Community ratingVisitor votes on StartupHub | 2.0/5 from 1 vote | Not published |
Moderna vs Poplar Therapeutics: common questions
Which is better, Moderna or Poplar Therapeutics?
On our 0-100 score Moderna rates higher (77/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Moderna and Poplar Therapeutics compare on the numbers?
Moderna leads on our overall score (77/100 against 51/100), agent readiness (49/100 against 40/100), domain rating (79/100 against 4/100), headcount (6,297 against 15), funding raised ($4.5B against $50.0M), LinkedIn following (780,086 against 1,205).
Read the full Moderna review and pricing or the Poplar Therapeutics review and pricing. You can also browse other Moderna alternatives we track.